Dyne Therapeutics, Inc. (DYN)
NASDAQ: DYN · Real-Time Price · USD
10.18
-1.28 (-11.14%)
Mar 31, 2025, 1:31 PM EDT - Market open
Dyne Therapeutics Market Cap
Dyne Therapeutics has a market cap or net worth of $1.15 billion as of March 31, 2025. Its market cap has decreased by -49.43% in one year.
Market Cap
1.15B
Enterprise Value
516.33M
1-Year Change
-49.43%
Ranking
Category
Stock Price
$10.18
Market Cap Chart
Since the IPO on September 17, 2020, Dyne Therapeutics's market cap has increased from $790.90M to $1.15B, an increase of 45.53%. That is a compound annual growth rate of 8.64%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 28, 2025 | 1.30B | -45.98% |
| Dec 31, 2024 | 2.40B | 193.72% |
| Dec 29, 2023 | 816.30M | 35.12% |
| Dec 30, 2022 | 604.12M | -0.31% |
| Dec 31, 2021 | 606.03M | -36.50% |
| Dec 31, 2020 | 954.35M | 20.67% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 738.61B |
| UnitedHealth Group | 472.03B |
| Johnson & Johnson | 394.52B |
| AbbVie | 363.15B |
| Novo Nordisk | 305.46B |
| AstraZeneca | 229.16B |
| Abbott Laboratories | 226.88B |
| Merck & Co. | 225.40B |